Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Thyroid Gland Papillary Carcinoma. Data from NIH RePORTER, last 36 months.
Thyroid Gland Papillary Carcinoma has active NIH research funding with 17 funded grants totaling $16.2M.
1 new grant started in the last 12 months.
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Thyroid Gland Papillary Carcinoma. Strongest funded area: Basic Science. Largest gap: Basic Science.
9 funded grants in Basic Science but only 0 related publications found for thyroid gland papillary carcinoma. This may indicate early-stage research that hasn't yet produced published results.
3 funded grants in Clinical Research but only 0 related publications found for thyroid gland papillary carcinoma. This may indicate early-stage research that hasn't yet produced published results.
2 funded grants in Biomarker / Diagnostics but only 0 related publications found for thyroid gland papillary carcinoma. This may indicate early-stage research that hasn't yet produced published results.
These grants mention Thyroid Gland Papillary Carcinoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.